Roche Holding Ltd
RHO · BX · CHF
CHF 361.85
−6.27 −1.70%todayNot financial advice.
- Open
- 361.85
- Day range
- 361.85 - 361.85
- 52-week range
- 273.95 - 381.28
- Volume
- 5
- Market cap
- 338.42B
- P/E ratio
- 23.61
- EPS
- 19.18
- Dividend yield
- 2.93%
- Beta
- 1.21
Performance
W
−1.70%
1M
−2.88%
3M
+6.69%
6M
+11.68%
YTD
+8.74%
Y
+19.61%
5Y
−5.67%
All
−4.75%
In the news
Oct 9
FDA Approves Genentech Tecentriq Combination for Stage III Colon Cancer
The FDA approved Genentech's Tecentriq combo for Stage III colon cancer, reducing recurrence or death risk by 50%.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/BX-RHO" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Roche Holding Ltd (RHO) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/BX-RHO">RHO stock price</a> by FreeTheAI Stocks</p>